Active · per the CBE, 27 September 2026

VECO Corporate Funding

BE0541622462

Rechtspersoon Public limited company 1 establishment

Rue des Merisiers 12, 1390 Grez-Doiceau

Active for

12 year, 10 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

VECO Corporate Funding from Grez-Doiceau, company number BE0541622462, closed financial year 2025 with a result of € -2,560 after tax. For that financial year VECO Corporate Funding recorded a gross margin of € -43,972 and equity of € 1 million. Compared with financial year 2024, the result moved from € -958 to € -2,560. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Healthy

€ 1 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2,560

▼ 167 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,002

▼ 94% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -45,752.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,413

▲ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -39,700 € -33,909 € -42,417 € -43,972 ▼ € 1,555
Profit after taxes € 1,878 € 7,553 € -958 € -2,560 ▼ € 1,602
Equity € 1,025,212 € 1,032,765 € 1,031,807 € 1,029,248
Total debts € 0 € 4,235 € 1,097 € 1,413 ▲ 29%
Cash € 40,213 € 9,341 € 47,905 € 3,002 ▼ 94%
Retained profit € -49,788 € -42,235 € -43,193 € -45,752 ▼ € 2,560
Balance sheet total € 1,025,212 € 1,037,000 € 1,032,904 € 1,030,661

Key figures of VECO Corporate Funding, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VECO Corporate Funding?

What happened at VECO Corporate Funding in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Eric LEBOSSE de LANNOY stepped down as director. NBB
  • 4P MANAGEMENT SA stepped down as director. NBB
  • Vincent LANGLADE stepped down as director. NBB
  • Olivier PAUL stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 2,560. Source: NBB ↗
  • Eric LEBOSSE de LANNOY became a director. NBB
  • 4P MANAGEMENT SA became a director. NBB
  • Vincent LANGLADE became a director. NBB

In short

From € 1,878 profit in 2022 to € 2,560 loss in 2025.

Paid € 1 in corporate taxes since 2022.

Best year ever: 2023, with € 7,553 profit.

Management

The stake of 4P MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VECO Corporate Funding
EMA PHARMACEUTICALS SAS 100%

The shares are held by 4P MANAGEMENT (19.8%). It owns 100% of EMA PHARMACEUTICALS SAS itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Eric LEBOSSE de LANNOY

Director

Also active at: 4P MANAGEMENT

since 2025 · until 2030

4P MANAGEMENT SA

Managing director · represented by Claude DEDRY

since 2025 · until 2030

Vincent LANGLADE

Director

since 2025 · until 2030

Olivier PAUL

Director

Also active at: 4P MANAGEMENT

since 2025 · until 2030

Shareholders

Participations

EMA PHARMACEUTICALS SAS

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Merisiers 12

1390 Grez-Doiceau

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0541.622.462
VAT number
BE 0541.622.462
Registered office
Rue des Merisiers 12, 1390 Grez-Doiceau
Names & denominations
VECO Corporate Funding
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
30 October 2013
Peppol
Not registered

Frequently asked questions

What is the address of VECO Corporate Funding?
The registered office of VECO Corporate Funding is located at Rue des Merisiers 12, 1390 Grez-Doiceau.
Is VECO Corporate Funding still active?
Yes. According to the CBE (27 September 2026) VECO Corporate Funding is active, legal situation “Normale toestand”, started on 30 October 2013.
Is VECO Corporate Funding registered on Peppol?
No, VECO Corporate Funding is currently not registered on the Peppol network.
What is the enterprise number of VECO Corporate Funding?
The enterprise number of VECO Corporate Funding is BE0541622462.
When was VECO Corporate Funding founded?
VECO Corporate Funding was founded on 30 October 2013.
Who owns VECO Corporate Funding?
The shares are held by 4P MANAGEMENT (19.8%). It owns 100% of EMA PHARMACEUTICALS SAS itself.